Hanna M. Ollila, PhD
Principal Investigator and Group Leader of Ollila Lab at the Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki.
Research and leadership
Dr. Hanna M. Ollila leads research on the genetic epidemiology of sleep and brain autoimmunity. Her group investigates sleep disorders, narcolepsy and circadian rhythms using population genetics, large-scale genomic studies and molecular approaches. At FIMM, she supervises an interdisciplinary team of researchers and doctoral students.
Education and research training
Hanna received her PhD in 2013 from the Department of Psychiatry at the University of Helsinki. She subsequently trained at Stanford University, studying the genetic basis of type 1 narcolepsy, and joined Jonathan Pritchard’s team in 2018. Her research training also included co-mentorship by Richa Saxena at Massachusetts General Hospital.
Institutional profile and publications
The University of Helsinki’s research group website lists Hanna M. Ollila as Group Leader.